Exponent Inc. (EXPO) is a leading American engineering and scientific consulting firm. The company's headquarters are located at Menlo Park, California, with many other offices across the U.S and around the world. Incorporated in 1967, Exponent has been a pioneering force in the realm of engineering, offering comprehensive solution architectures across a multitude of domains. Largely, it serves clients from various sectors such as automotive, construction, energy, government, health, insurance among others.
Exponent describes its mission as solving commercially relevant problems by leveraging a multidisciplinary approach to address technical challenges that other businesses or government entities face. It prides itself on being the premier engineering consulting firm renowned for integrity, excellence, dedication, and independence.
The consulting services of Exponent Inc. are diverse, encompassing a wide range of specializations from Biomechanics, Materials Science, to Structural Engineering, and Environmental Science. The firm is known for utilizing critical scientific research and advanced analysis to help its clients innovate, manage risk, and achieve business and safety objectives. This is made possible by its dedicated team of scientists, physicians, engineers, and regulatory consultants who put their years of expertise to find solutions to the most complex technical issues.
Apart from its impressive consulting services offerings, Exponent Inc. is also recognized for its substantial investments in research and development (R&D). This tech-forward approach positions the company at the forefront of engineering and scientific consulting as they deliver pragmatic solutions that satisfy both regulatory and commercial demands.
Exponent Inc. is publicly traded in the NASDAQ Global Select Market under the stock symbol EXPO. The company's financial performance has remained resilient, reflecting its excellent business model. The company's revenue has consistently risen over the years, driven by contracts from a multitude of organizations that value the expertise, skill, and agility of Exponent's team.
In conclusion, Exponent Inc. carries an exemplary reputation in the relevant industry sectors for its commitment to providing robust solutions to technical, scientific, and business problems. As EXPO continues to grow, it reaffirms its place as a leading engineering and scientific consulting firm, propelling its clients towards better risk management, greater innovation, and business success through the power of advanced engineering and analysis.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article provides a quantitative analysis of Exponent Inc. (NASDAQ: EXPO), highlighting strong near and mid-term sentiment but a weak long-term outlook. It presents AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, support, and resistance levels for the stock. The analysis suggests compelling upside potential due to the absence of resistance levels above the current price.
Exponent (EXPO) has seen a recent rebound in its share price, with a 22.52% return over the past 90 days. The article explores the valuation gap, noting that while the company is considered 14.4% undervalued with a fair value of $81.67, its current P/E ratio of 29.7x is above both its estimated fair ratio and peer average. This suggests a mix of optimism due to growth prospects in AI safety and advanced medical technologies, and caution due to flat revenues and declining utilization.
Exponent CEO Catherine Corrigan sold 1,707 shares of Exponent stock for $113,144 on August 17, after exercising non-qualified stock options for 2,379 shares at $29.05 on the same day. This transaction leaves her with 129,108 shares owned in the company. The information was generated by AI based on an EDGAR filing from Exponent Inc.
Assenagon Asset Management S.A. has initiated a new position in Exponent, Inc. (NASDAQ:EXPO), investing approximately $2.31 million by purchasing 39,342 shares. Exponent recently exceeded quarterly earnings expectations with $0.60 EPS on $171.61 million revenue, and declared a quarterly dividend of $0.31 per share. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $81.
Quantinno Capital Management LP significantly increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 114.3% in Q1, purchasing 19,528 additional shares, bringing its total holding to $2.39 million. Other institutional investors also adjusted their positions in Exponent, a company with strong institutional ownership (92.37%). Exponent reported solid Q1 earnings, exceeding estimates with $0.60 EPS and 12% year-over-year revenue growth, and declared a quarterly dividend of $0.31 per share.